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INTRODUCTION

Methicillin-resistant Staphylococcus aureus (commonly known as
MRSA) is a strain of Staphylococcus aureus bacteria that is resistant to many antibiotics. It can cause skin infections, respiratory infections, sepsis, and infections in essentially any organ system. Methicillinresistant Staphylococcus aureus has gathered significant attention in the medical literature because it causes nosocomial and communityacquired infections that are associated with serious morbidities and high mortality rates, and it is the most common pathogen causing surgical incision infections. This bacterium has also attracted much attention in the public sector because it has been sensationalized in the popular media as the "superbug" and as the "flesh-eating bacteria" that causes necrotizing fasciitis.
Necrotizing fasciitis is a relatively rare pathology, and it can be caused by other pathogens, but nonetheless MRSA is a dangerous bacterium.
It is endemic in healthcare facilities, there is evidence that the incidence of community-acquired MRSA infections is rising, and there is no doubt that MRSA-related infections are associated with poor outcomes. Fortunately, with timely identification and proper treatment, MRSA-related infections can be successfully treated and with good infection control the transmission of MRSA can be significantly reduced.
THE STAPHYLOCOCCUS AUREUS BACTERIUM
The Staphylococcus aureus bacterium is a gram-positive organism that is part of the normal human flora. It is commonly found on the skin nursece4less.com nursece4less.com nursece4less.com nursece4less.com nursece4less.com 6 and approximately 25% to 50% of the population may be asymptomatic carriers at any one time and have the bacterium on their skin, either chronically or transiently: colonization with Staphyloccus aureus is more common in insulin-dependent diabetics, people who are infected with HIV, people who need hemodialysis on a chronic basis, and people who have damaged skin. 1 Methicillinresistant Staphylococcus aureus is commonly found in the anterior nares, the vagina, the axilla, the perineum, and the oropharynx.
(Note: Colonization is the implantation and growth of a microorganism on a host).
Staphylococcus aureus has long been known to be a dangerous pathogen, not particularly because of its inherent virulence but because of its ability to establish itself in human hosts. All bacteria and viruses have the capability of causing harm and evading host defenses, but Staphylococcus aureus is especially well suited to do so because these attributes are well developed in the bacterium.
Specifically, Staphylococcus aureus and MRSA both: [2] [3] [4]  Have a strong ability to evade host defenses. This is accomplished through several mechanisms: forming a microcapsule around itself; expression of protein A, a surface protein that can act to disguise Staphylococcus aureus from the host's immune system and help the bacterium resist phagocytosis, and; the presence of coagulase, an enzyme that also helps the bacterium resist phagocytosis.
 Can use enzymes such as hyaluronate lyase, protease, and staphylokinase to break through tissues to establish infection.
nursece4less.com nursece4less.com nursece4less.com nursece4less.com nursece4less.com 7  Produce cytotoxins, pyrogenic toxins, and exfoliative toxins.
 Have the ability to survive for up to 6 months on medical equipment, gloves, hard surfaces, etc.
Methicillin-resistant Staphylococcus aureus has an additional attribute that makes this bacterium particularly dangerous; it cannot be treated with many of the commonly used antibiotics. The bacterium has a protein on the cell wall -the penicillin-binding protein -that has a very low affinity for the β-lactam antibiotics, 5 
Knowledge Check:
Methicillin was developed after penicillin and it is in the penicillin class of antibiotics.
Methicillin is no longer manufactured -other antibiotics were found to be more effective and more stable -but the term methicillin-resistant is still used to describe strains of Staphylococcus aureus that are resistant to penicillins.
nursece4less.com nursece4less.com nursece4less.com nursece4less.com nursece4less.com 8 6 it is the most common cause of surgical site infections, 7 and it is the second-most common cause of bacteremia. 8 Up until the late '90s, MRSA had been seen only in healthcare settings and it was considered to be a nosocomial infection that occurred in patients who had specific risk factors, but in 1999 the first confirmed cases of community-acquired MRSA were found in the US. 9 In recent years the incidence of hospital-acquired MRSA has been declining, 10 but the incidence of community-acquired MRSA has been increasing, and there is speculation that the community acquired type of MRSA will become the dominant form. 11, 12 Community-acquired MRSA is a different strain than hospital-acquired but there is evidence that the line between the two has become somewhat blurred and cases of community-acquired MRSA are increasingly being seen in the healthcare setting.
EPIDEMIOLOGY OF MRSA INFECTIONS
nursece4less.com nursece4less.com nursece4less.com nursece4less.com nursece4less.com 9 the respiratory tract, urinary tract, and other sites of infection each account for 1% or less of community-acquired MRSA infections. 13 Hospital-acquired MRSA infections also involve the skin, the bones and joints, the respiratory tract, the urinary tract, and cause bacteremia and sepsis, as well. 14 Knowledge Check:
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS
Skin and soft tissue infections
A MRSA infection can be caused by someone's own skin flora or from pathogens transmitted to that person from someone else or a contaminated environment.
Necrotizing fasciitis
Necrotizing fasciitis is a rare and very dangerous skin infection that can be caused by MRSA, as well as by other pathogens. The exact incidence of MRSA as the pathogen responsible for necrotizing fasciitis is not known, but a recent study found that 39% of the cases examined were caused by MRSA. 22 Many patients with necrotizing fasciitis first complain of fever and intense pain, and then develop skin changes that can be mistaken for cellulitis, deep vein thrombosis, a hematoma, phlebitis, or other local or systemic pathologies. 23 Risk factors for adults for developing this infection include diabetes mellitus, IV drug use, peripheral vascular disease, and smoking. 24 For children, the risk factors include chronic illness, recent infection with varicella, surgery, and trauma. 25 Although there may be some skin changes and lesions caused by necrotizing fasciiitis, the major tissue damage is subcutaneous, so the initial presentation -intense paincombined with the lack of skin damage or the lack of dramatic skin lesions and the non-specific laboratory findings make necrotizing fasciitis difficult to diagnose. However, early diagnosis is crucially important as the disease is rapidly progressive and potentially very 
Bacteremia and sepsis
Staphylococcus aureus is the second leading cause of blood stream infections, and it is the leading cause of sepsis in patients in ICUs. 32, 33 Bacteremia caused by MRSA has been associated with a mortality rate of approximately 32%. 34
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Infections caused by MRSA can also affect the urinary tract, the eyes, and the heart (infective endocarditis), and cause toxic shock syndrome.
HOW MRSA INFECTIONS BEGIN AND BECOME ESTABLISHED
There are essentially two stages of a Staphylococcus aureus infection:
1) exposure to the pathogen and establishment of a local infection, and; 2) evading the host's immune response.
Exposure to MRSA/Establishment of Infection
Exposure to MRSA can be from the patient's normal flora or exposure to a colonized person or a contaminated environment. 41, 42 x-ray cassettes, 43 and surfaces such as cloth curtains, computer keyboards, countertops, glass, and tile. 44 The infection is established when the integrity of the skin is broken,
i.e., by an abrasion, IV catheter insertion, or any medical procedure and the bacterium has a point of entry to the tissue and/or bloodstream.
Evasion of Host Immune Response
Once the bacteria have access to the tissue or the bloodstream they begin to replicate. Staphylococcus aureus and MRSA, as was mentioned previously, are well equipped to evade host defenses, and they do so by forming a microcapsule around the bacterium that protects them from host response, expression of protein A, a surface protein that can act to disguise Staphylococcus aureus from the host's immune system and help the bacterium resist phagocytosis, and using enzymes that help the bacterium resist phagocytosis and break down tissues.
TRANSMISSION OF MRSA
Transmission of MRSA is primarily through skin contact. The bacteria can be carried or transmitted from an infected person to someone else, or it can be transmitted from an infected object in the environment; and, the latter is thought to be a much less common mode of transmission. In the healthcare setting, patients are the 
Knowledge Check:
It was mentioned in a previous section of this module that MRSA can persist in the environment for many months, and MRSA is very common in the environment. A 2012 study found that 11.8% of surfaces tested in three community hospitals were contaminated with MRSA. 
TREATMENT OF MRSA INFECTIONS
The following treatment recommendations were developed by the Infectious Diseases Society of America, 47 
Treatment of Skin and Soft Tissue Infections
Cutaneous abscess:
For adults, incision and drainage should be performed; this is the first step in treatment. After this has been done, antibiotic therapy should be started if the patient: 1) has severe and/or extensive disease (i.e., multiple sites of infection); 2) has an infection that is rapidly progressing; 3) has cellulitis; 4) has signs or symptoms of a systemic illness caused by the infection; 5) is immunosuppressed; 6) has significant co-morbidities; 7) is very young or very old; 8) has an abscess in an area that is difficult to incise and drain, i.e., the face, hands, genitals, or; does not respond to incision and drainage.
Outpatients can be empirically treated with clinadamycin, trimethoprim-sulfamethoxazole, a tetracycline, or linezolid. Tetracycline should not be used in children less than 8 years.
Knowledge Check: It was mentioned in a previous section that MRSA is resistant to lincosamides such as clindamycin. This is true is some circumstances, but in treating some MRSA infections clindamyicn can be effective and is used.
Bactermia and endocarditis:
Adults who have uncomplicated bactermia should be treated with IV quite extensive and will not be covered here: refer to the guidelines for specific information.
Pneumonia:
Patients who have community-acquired or hospital-acquired MRSA pneumonia should be treated with IV or PO clindamycin or linezolid or IV vancomycin. Pediatric cases should be treated with the same drugs.
The treatment course should be 7-21 days, depending on the extent of the infection.
Osteomyelitis:
Surgical debridement and drainage of soft tissue abscesses should be done. The optimal antibiotic therapy has not been determined, but IV daptomycin or vancomycin are typically used. The patient can also be treated with a combination of PO and IV drugs, i.e., clindamycin, linezolid, trimethoprim-sulfamethoxazole, and rifampin. Children are treated with the same drugs, but trimethoprim-sulfamethoxazole is not used. The optimal duration of treatment for MRSA-related osteomyelitis has not been determined, but the guidelines recommend at least eight weeks of antibiotic therapy and some authorities recommend one to two months of treatment after those eight weeks.
The duration of antibiotic therapy for children should be four to six weeks.
Septic arthritis:
The affected joint should be debrided and drained, and the patient should be treated using the same regimen as would be used for a patient with MRSA-related osteomyelitis. The duration of therapy nursece4less.com nursece4less.com nursece4less.com nursece4less.com nursece4less.com 18
should be three to four weeks. If the affected joint has a prosthetic device, the treatment is essentially the same as that for osteomyelitis, but the location of the prosthetic device, how long it has been in place, and the duration of the infection will be the factors that will determine what antibiotics will be used and for how long. The treatment of children with MRSA-related septic arthritis is essentially the same as that for adults, but the duration of therapy should be a minimum of three to four weeks.
Central nervous system infections: 
PREVENTION OF TRANSMISSION
Preventing transmission of MRSA is critically important, and as nurses have extensive patient contact they must understand and practice good infection control. It has been clearly shown that conscientious use of infection control practices -especially hand washing -can reduce the transmission of MRSA. [48] [49] [50] The CDC recommends the use Standard Precautions to prevent transmission of MRSA, 51 i.e., hand hygiene, gloving, mouth, nose and eye protection, the use of a gown when needed, and the appropriate handling and disposal of contaminated items. The CDC also MRSA from people who are carriers decreases transmission rates or the incidence of infection. 56, 57 Screening for MRSA is done by swabbing the nostrils, the perineal area, and the skin (where appropriate) and culturing the swab. Decolonization involves applying 2% mupirocin ointment to the nostrils and using 4% chlorhexidine gluconate skin wash (i.e., Hibiclens®). 
